Thrust & Parry: CVT And Gilead Look To Lock Out Astellas With Planned Merger
This article was originally published in The Pink Sheet Daily
Executive Summary
Gilead’s surprise $20 per share bid tops Astellas’ $16 per share offer, highlights Gilead’s increasing focus on cardiovascular space.